AI Breakthroughs in Alzheimer’s Research: $2 Million Prize Awarded to Pioneering Teams

Copenhagen, Denmark – March 23, 2026 – In a significant stride towards combating Alzheimer’s disease, the Alzheimer’s Disease Data Initiative (AD Data Initiative) has announced Biomni-AD and Prima Mente as the winners of the $1 million Alzheimer’s Insights AI Prize. Originally designed to award a single $1 million prize, the competition was expanded to recognize the exceptional quality of submissions and the urgent need for innovative approaches in Alzheimer’s and related dementias (ADRD) research, resulting in a total prize pool of $2 million.

The Growing Burden of Alzheimer’s Disease

Alzheimer’s disease is projected to affect an estimated 152 million people globally by 2050 [1], underscoring the critical need for advancements in understanding and treating this devastating condition. The complexity of neurodegenerative diseases, involving multiple biological pathways and varying causes among patients, presents a substantial challenge to traditional research methods. The increasing volume of clinical, genomic, imaging, and real-world data, often fragmented and overwhelming, necessitates new tools for effective analysis.

Agentic AI: A New Frontier in Alzheimer’s Research

Agentic AI – artificial intelligence systems capable of independent planning, reasoning, and action – offers a promising pathway to accelerate progress in ADRD research. The AD Data Initiative recognized this potential and launched the Alzheimer’s Insights AI Prize to foster the development of breakthrough AI solutions.

The Winning Teams and Their Innovations

Biomni-AD (Stanford University and Icahn School of Medicine at Mount Sinai)

Biomni-AD’s winning solution is an AI-powered “co-scientist” designed specifically for Alzheimer’s research. This system utilizes agentic AI to perform time-consuming research tasks with greater speed and accuracy than general AI models, enabling researchers to move more efficiently from data to actionable insights [2].

Prima Mente

Prima Mente’s winning solution, PARTHENON, is an integrated modeling and discovery platform that functions as a virtual “wet lab.” It allows researchers to model experiments using virtual cells and leverage an AI co-scientist named “Athena,” compressing work that traditionally takes weeks into mere minutes [2]. The platform aims to create a global lab for Alzheimer’s research by democratizing both model training and hypothesis generation.

Making the Tools Accessible

The tools developed by Biomni-AD and Prima Mente will be made freely available to researchers worldwide through the AD Data Initiative’s AD Workbench, a flagship data sharing and analytics platform for Alzheimer’s research [2].

A Collaborative Future for Alzheimer’s Research

Launched in August 2025, the Alzheimer’s Insights AI Prize attracted over 180 submissions [2]. All ten semifinalist teams from the competition have been invited to join AI Collaboratories – collaborative hubs designed to unite AI innovators with leading Alzheimer’s researchers. This initiative aims to ensure that these innovations continue to develop, are validated, and reach the researchers and patients who need them most. Some of these tools will be showcased at the Alzheimer’s Association International Conference in London later this year [3].

“Our judges evaluated each finalist on scientific rigor, technical originality, and the likelihood that the work could materially accelerate Alzheimer’s research and discovery, with real potential to help enable better treatments and, a cure,” said Gregory Moore, Senior Advisor at Gates Ventures and the AD Data Initiative [2].

About the Alzheimer’s Disease Data Initiative

The Alzheimer’s Disease Data Initiative (AD Data Initiative) is a coalition of leading advocacy, government, industry, and philanthropic organizations dedicated to accelerating progress towards new diagnostics, treatments, and cures for Alzheimer’s disease and related dementias. More information can be found at www.alzheimersdata.org.